There is an increasing need to build research capacity to address the emerging threat of Lyme disease (LD) in Canada. We are establishing the Canadian Lyme Disease Research Network (CLyDRN) to provide national capacity to conduct integrated, multidisciplinary, evaluative, and discovery research. CLyDRN will support, link, and coordinate research activities conducted in academia, public health, health care, and industry. CLyDRN’s research planning and activities will be conducted in collaboration with stakeholders including patients, caregivers and family members, community leaders and members of the general public (citizens), health care providers (HCPs), and public health professionals (PHPs). The goal of this research network is to improve prevention, diagnosis, and treatment of LD in Canada.
This vision will be accomplished through a multi-centric, collaborative and team-based approach. The research group will make use of existing resources, and expertise from various academic and public health institutions as well as professional associations and commercial enterprises.
Innovation and Excellence. The research network would be the first group of its kind at a Canadian university and would promote new and meaningful research
Collaboration. The goal of the research group would be to bring experts from various disciplines together, including clinicians, microbiologists, mathematicians, biologists, and public health professionals amongst others to form a multidisciplinary team with a common interest in LD and other tick-borne illnesses
Relevance. The research group would explore areas significant to Canadians and their needs, given that tick-borne illnesses are becoming an increasingly pressing issue
Enabled by the network, our vision of reducing the impact of LD through addressing knowledge gaps in Canada will be accomplished through this multidisciplinary approach which will mobilize and build LD-specific capacity and training opportunities, improve clinical science and practice, provide best evidence in testing and patient care, improve patient and population prevention outcomes and inform evidence-based policy.